64
c. Haass
Thinakaran G, Regard JB, Bouton CM, Harris CL, Price DL, Borchelt DR,
Sisodia SS (1998) Stable association of presenilin derivates and absence of
presenilin interactions with APP. Neurobiol Dis 4:438-453.
Tomita T, Tokuhiro S, Hashimoto T, Aiba K, Saido T, Maruyama K, Iwatsubo
T (1998) Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of trunctated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42. J Bioi Chern 273 :21153-21160
Wolfe M, Xia W, Ostaszewski B, Diehl T, Kimberly W, Selkoe D (1999) Two
transmembrane aspartates in presenilin-I required for presenilin endoproteolysis and y-secretase activity. Nature 398:513-517.
Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJS, Trumbauer
ME, Chen HY, Price DL, Van der Ploeg LHT, Sisodia SS (1997) Presenilin
I is required for Notch 1 and DIll expression in the paraxial mesoderm.
Nature 387:288-292
Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, Rogaeva
EA, Xu M, Liang Y, Duthie M, St. George-Hyslop PH, Fraser PE (1998)
The presenilin I protein is a comonent of a high molecular weight intracellular co~plex that contains beta-catenin. J BioI Chern 273: 16740-16475
Zhang Z, Hartmann H, Do VM, Abramowski D, Strchler-Pierrat C, Staufenbiel
M, Sommer B, van de Wetering M, Clevers H, Saftig P, De Strooper B,
Yankner BA (1998) Destabilization of beta-catenin by mutations in presenilin-I potentiates neuronal apoptosis. Nature 395:698-702
Précédent

- 77/251

Suivant